133 related articles for article (PubMed ID: 17148583)
1. Comprehensive analysis of homeobox genes in Hodgkin lymphoma cell lines identifies dysregulated expression of HOXB9 mediated via ERK5 signaling and BMI1.
Nagel S; Burek C; Venturini L; Scherr M; Quentmeier H; Meyer C; Rosenwald A; Drexler HG; MacLeod RA
Blood; 2007 Apr; 109(7):3015-23. PubMed ID: 17148583
[TBL] [Abstract][Full Text] [Related]
2. Establishment of the TALE-code reveals aberrantly activated homeobox gene PBX1 in Hodgkin lymphoma.
Nagel S; Pommerenke C; Meyer C; MacLeod RAF; Drexler HG
PLoS One; 2021; 16(2):e0246603. PubMed ID: 33539429
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of homeobox gene SIX1 in Hodgkin lymphoma.
Nagel S; Meyer C; Kaufmann M; Drexler HG; MacLeod RA
Oncotarget; 2015 Nov; 6(37):40112-26. PubMed ID: 26473286
[TBL] [Abstract][Full Text] [Related]
4. Bmi-1 is induced by the Epstein-Barr virus oncogene LMP1 and regulates the expression of viral target genes in Hodgkin lymphoma cells.
Dutton A; Woodman CB; Chukwuma MB; Last JI; Wei W; Vockerodt M; Baumforth KR; Flavell JR; Rowe M; Taylor AM; Young LS; Murray PG
Blood; 2007 Mar; 109(6):2597-603. PubMed ID: 17148591
[TBL] [Abstract][Full Text] [Related]
5. BMI1 silencing enhances docetaxel activity and impairs antioxidant response in prostate cancer.
Crea F; Duhagon Serrat MA; Hurt EM; Thomas SB; Danesi R; Farrar WL
Int J Cancer; 2011 Apr; 128(8):1946-54. PubMed ID: 20568112
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of BMI-1 correlates with drug resistance in B-cell lymphoma cells through the stabilization of survivin expression.
Bhattacharyya J; Mihara K; Ohtsubo M; Yasunaga S; Takei Y; Yanagihara K; Sakai A; Hoshi M; Takihara Y; Kimura A
Cancer Sci; 2012 Jan; 103(1):34-41. PubMed ID: 21999765
[TBL] [Abstract][Full Text] [Related]
7. t(4;8)(q27;q24) in Hodgkin lymphoma cells targets phosphodiesterase PDE5A and homeobox gene ZHX2.
Nagel S; Schneider B; Rosenwald A; Meyer C; Kaufmann M; Drexler HG; MacLeod RA
Genes Chromosomes Cancer; 2011 Dec; 50(12):996-1009. PubMed ID: 21987443
[TBL] [Abstract][Full Text] [Related]
8. Reciprocal expression of Bmi1 and Mel-18 is associated with functioning of primitive hematopoietic cells.
Kajiume T; Ohno N; Sera Y; Kawahara Y; Yuge L; Kobayashi M
Exp Hematol; 2009 Jul; 37(7):857-866.e2. PubMed ID: 19409954
[TBL] [Abstract][Full Text] [Related]
9. Bmi1 regulates cell fate via tumor suppressor WWOX repression in small-cell lung cancer cells.
Kimura M; Takenobu H; Akita N; Nakazawa A; Ochiai H; Shimozato O; Fujimura Y; Koseki H; Yoshino I; Kimura H; Nakagawara A; Kamijo T
Cancer Sci; 2011 May; 102(5):983-90. PubMed ID: 21276135
[TBL] [Abstract][Full Text] [Related]
10. PU.1 is a potent tumor suppressor in classical Hodgkin lymphoma cells.
Yuki H; Ueno S; Tatetsu H; Niiro H; Iino T; Endo S; Kawano Y; Komohara Y; Takeya M; Hata H; Okada S; Watanabe T; Akashi K; Mitsuya H; Okuno Y
Blood; 2013 Feb; 121(6):962-70. PubMed ID: 23212521
[TBL] [Abstract][Full Text] [Related]
11. ERK5 induces ankrd1 for catecholamine biosynthesis and homeostasis in adrenal medullary cells.
Obara Y; Nagasawa R; Nemoto W; Pellegrino MJ; Takahashi M; Habecker BA; Stork PJS; Ichiyanagi O; Ito H; Tomita Y; Ishii K; Nakahata N
Cell Signal; 2016 Mar; 28(3):177-189. PubMed ID: 26739108
[TBL] [Abstract][Full Text] [Related]
12. Dysregulated expression of stem cell factor Bmi1 in precancerous lesions of the gastrointestinal tract.
Tateishi K; Ohta M; Kanai F; Guleng B; Tanaka Y; Asaoka Y; Tada M; Seto M; Jazag A; Lianjie L; Okamoto M; Isayama H; Tada M; Yoshida H; Kawabe T; Omata M
Clin Cancer Res; 2006 Dec; 12(23):6960-6. PubMed ID: 17145814
[TBL] [Abstract][Full Text] [Related]
13. Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile.
Gibcus JH; Tan LP; Harms G; Schakel RN; de Jong D; Blokzijl T; Möller P; Poppema S; Kroesen BJ; van den Berg A
Neoplasia; 2009 Feb; 11(2):167-76. PubMed ID: 19177201
[TBL] [Abstract][Full Text] [Related]
14. Bmi1 cooperates with Dnmt1-associated protein 1 in gene silencing.
Negishi M; Saraya A; Miyagi S; Nagao K; Inagaki Y; Nishikawa M; Tajima S; Koseki H; Tsuda H; Takasaki Y; Nakauchi H; Iwama A
Biochem Biophys Res Commun; 2007 Feb; 353(4):992-8. PubMed ID: 17214966
[TBL] [Abstract][Full Text] [Related]
15. Abnormal PcG protein expression in Hodgkin's lymphoma. Relation with E2F6 and NFkappaB transcription factors.
Sánchez-Beato M; Sánchez E; García JF; Pérez-Rosado A; Montoya MC; Fraga M; Artiga MJ; Navarrete M; Abraira V; Morente M; Esteller M; Koseki H; Vidal M; Piris MA
J Pathol; 2004 Dec; 204(5):528-37. PubMed ID: 15470680
[TBL] [Abstract][Full Text] [Related]
16. Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer.
Berezovska OP; Glinskii AB; Yang Z; Li XM; Hoffman RM; Glinsky GV
Cell Cycle; 2006 Aug; 5(16):1886-901. PubMed ID: 16963837
[TBL] [Abstract][Full Text] [Related]
17. The polycomb gene product BMI1 contributes to the maintenance of tumor-initiating side population cells in hepatocellular carcinoma.
Chiba T; Miyagi S; Saraya A; Aoki R; Seki A; Morita Y; Yonemitsu Y; Yokosuka O; Taniguchi H; Nakauchi H; Iwama A
Cancer Res; 2008 Oct; 68(19):7742-9. PubMed ID: 18829528
[TBL] [Abstract][Full Text] [Related]
18. Expression of SSX genes in the neoplastic cells of Hodgkin's lymphoma.
Colleoni GW; Capodieci P; Tickoo S; Cossman J; Filippa DA; Ladanyi M
Hum Pathol; 2002 May; 33(5):496-502. PubMed ID: 12094374
[TBL] [Abstract][Full Text] [Related]
19. Targeted depletion of BMI1 sensitizes tumor cells to P53-mediated apoptosis in response to radiation therapy.
Alajez NM; Shi W; Hui AB; Yue S; Ng R; Lo KW; Bastianutto C; O'Sullivan B; Gullane P; Liu FF
Cell Death Differ; 2009 Nov; 16(11):1469-79. PubMed ID: 19575017
[TBL] [Abstract][Full Text] [Related]
20. A Polycomb-mir200 loop regulates clinical outcome in bladder cancer.
Martínez-Fernández M; Dueñas M; Feber A; Segovia C; García-Escudero R; Rubio C; López-Calderón FF; Díaz-García C; Villacampa F; Duarte J; Gómez-Rodriguez MJ; Castellano D; Rodriguez-Peralto JL; de la Rosa F; Beck S; Paramio JM
Oncotarget; 2015 Dec; 6(39):42258-75. PubMed ID: 26517683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
